Brisbane-based vaccine delivery technology Vaxxas has announced initiation of a Phase 1 clinical trial for flu shots administered by the company’s high-density microarray patch (HD-MAP.) According to a statement from the company on Friday, the trial will take place at three University of the Sunshine Coast’s clinical research sites – in Brisbane, Morayfield and Sippy…
Unmanned aerial vehicle (UAV) engine manufacturer Orbital Corporation has announced a revenue boost from efforts to broaden its customer base. Orbital reported today first half revenue of $14.1 million, up from $11.2 million in the previous corresponding period. The Perth company, once focused a single customer, Boeing’s In situ division, is now building engines or…
Arovella, Imugene progress drug combination trials ASX-listed companies Arovella Therapeutics and Imugene have announced a successful outcome from the initial in vitro experiments conducted as part of their research collaboration, and are progressing to the next phase of testing. According to a statement on Friday, results show that the combination of Arovella’s CAR19-iNKT cell therapy…
US solar PV tracking technology developer Array Technologies is to set up an Australian manufacturing plant at a yet to be decided location. The Albuquerque company will develop the factory, the first sych facility in Australia, following the the award of a contract to supply solar trackers for the 130MWdc Glenrowan, Victoria solar farm project.…
Zero emission transport developer Zero Automotive has delivered its third Australian-built, solar chargeable, underground-ready battery electric light vehicle (bELV, pictured). The ZED70 Ti traytop utility, using LTO battery technology which does not suffer from thermal runaway, was delivered to IGO Ltd’s Nova nickel-copper-cobalt operation in Western Australia. This is the second vehicle conversion, and the…
